GATA ROIDAL RECORD Q FILING NEWZZZ !! Reports Record First

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2012 at 9:25 AM

[b]GATA > ROIDAL RECORD Q FILING NEWZZZ !! Reports Record First Quarter Revenues, Adoption Of IFRS Accounting Standard In Anticipation Of Applying For Listing On The NASDAQ Bulletin Board
[/b]
2012-11-14 07:00 ET - News Release

MUMBAI, India, Nov. 14, 2012 /PRNewswire/ -- Groupe Athena, Inc. (Pink sheets: GATA) announced today record revenues of $15,367,544 for the first quarter ending September 30, 2012, which is a 25% increase over the same period in 2011. Net after tax income for the period was $1,307,293 or $.03 per share which included a one time expense of $407,181 related to the purchase of the company's new facility in India. Trailing twelve month (ttm) earnings remained strong at nearly $.10 per share. The company also has a very healthy cash position and no long term debt.

The Company's Chairman, D. Purohit stated, "The pharma industry within our region is still very robust and Groupe Athena is extremely well positioned to continue on our current growth track for the foreseeable future. And with the recently reported asset additions which allow us to perform more services in-house, our margins are also increasing significantly."

In other news the Company has completed their recent transition from GAAP to the International Financial Reporting Standard (IFRS) for all future audited financials. The Company's annual report for the recent fiscal yearend on June 30, 2012 which was released on August 20, 2012 was audited using IFRS. With the completion of the audit for this fiscal year end on June 30, 2013 the company will seek to qualify for listing on the NASDAQ Bulletin Board quotation system.

To review the complete quarterly report please go to www.otcmarkets.com/stock/GATA/quote and click on "Financials."

The company reports it is still committed to funding all capital expenditures entirely from internal cash accruals without any shareholder dilution or debt increases.

As was previously stated, the Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.

About Groupe Athena, Inc.

Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.

The company has a research and marketing facility in India that currently employs 17 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com

For more information contact:
Paul Cornell
Corporate Shareholder Relations, Inc.
pcornell@totalpublicrelations.com

Safe Harbor Statement
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets.

SOURCE Groupe Athena, Inc.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yellow Phosphorus Market Set for Growth to $6.21B

What's Cooking in the Phosphorus Market? Kicking off with some seasoning for your thoughts. Picture this: yellow phosphorus isn't just another chemical compound sitting quietly in a lab fridge. Nope, we've got an industrial powerhouse here, folks. Projected to leap from USD 4.84 billion in 2026 to a hearty USD 6.21 billion by 2031, this market's chugging along at a decent...

Pyxus Starts Exchange Offer for 8.50% Notes, 2027

Pyxus Restructures Via Exchange Offer Pites, it's time for Pyxus International to show its hand. The global agricultural player has rolled up its sleeves, kicking off an exchange offer for its 8.50% notes maturing in 2027. With $148.3 million hanging in the balance, this move is their shot at managing debt and keeping things steady—like a farmer making sure the...

PC Richard & Son Offers Big Black Friday Savings

Holiday Prep Kicks Into High Gear As November ticks on, folks are diving headfirst into the frenzy of holiday planning and spending. What better time for a salvo of sales from P.C. Richard & Son? The appliance stalwart is throwing down the gauntlet with hefty discounts and some intriguing offers on TVs, mattresses, and more. With Black Friday looming, the savvy shopper...

The DOG CATCHER: A New Spin on Pet Waste Cleanup

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Stellus Capital Delivers Solid Q3 Amid Turbulent Times

Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...

Straight-Talking Look at Zepp Health's Q3 Preview

Prepping for Zepp Health's Financial Disclosure There's something about earnings season that gets the blood pumping. Maybe it’s the anticipation of numbers that can either make us jump for joy or toss us into a pit of despair. November 22 promises to be an intriguing day for folks with eyes on Zepp Health. They're set to spill the beans on their third-quarter...

Entrepreneurs Thrive in Utah with Zions' SBA Boost

Let's kick this off with a nod to the hustlers out there making Utah one of the hottest spots for small business growth in the U.S. Thanks to some serious backing by Zions Bank, we're seeing a boom that's hard to ignore. They're not just any lender—these guys are the top dog in SBA 7(a) loans in Utah in 2026, helping entrepreneurs chase their dreams, even with inflation...

Lawyers Juggle AI's Promise and Perils in 2026

AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...

QuidelOrtho Shares Plunge 14% Amid Legal Scrutiny

QuidelOrtho's Rocky Road Oh, it's been a roller coaster for QuidelOrtho's stock. Lately, it’s like holding onto a greased pole in a thunderstorm. November 9th, 2026, wasn't a friend to QDEL shareholders; the stock's down about 14%, and now some legal eagles want to know if there's more to the story. When you go poking around in the financials and spotlight that nasty...

Innovative Sun Visor Tackles Trucking's Glare Issue

Shedding Light on Glare-Free Trucking Ever tried squinting your way down the highway with the sun blinding you through that annoying gap in your visor? Ask any trucker, and they'll tell you that battling glare isn't just about comfort, it's about staying safe and alert. Enter the new patent-pending invention out of Dallas that's here to address this gnawing issue—the...